Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 4/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8935451 | 0.92 | CHRM2 (0.43) | CHRM2CHRM1CHRM4CHRM3MEN1 | |
| SCHEMBL15329099 | 0.92 | CHRM2 (0.43) | CHRM2CHRM1CHRM4CHRM3MEN1 | |
| SCHEMBL9698254 | 0.76 | CHRM1 (0.38) | CHRM2CHRM1CHRM4CHRM3MEN1 | |
| SCHEMBL7266907 | 0.75 | CHRM1 (0.49) | CHRM2CHRM1CHRM4CHRM3 | |
| SCHEMBL10369501 | 0.74 | CHRM1 (0.51) | CHRM2CHRM1CHRM4CHRM3 | |
| SCHEMBL8935492 | 0.72 | CHRM2 (0.46) | CHRM2CHRM1CHRM4CHRM3MEN1 | |
| SCHEMBL9523751 | 0.72 | CHRM2 (0.41) | CHRM2CHRM1CHRM4CHRM3MEN1 | |
| SCHEMBL7330432 | 0.71 | CHRM1 (0.42) | CHRM2CHRM1CHRM4CHRM3 | |
| Oxalic Acid SCHEMBL10367531 | 0.71 | CHRM1 (0.45) | CHRM2CHRM1CHRM4CHRM3 | |
| SCHEMBL7493133 | 0.70 | CHRM2 (0.42) | CHRM2CHRM1CHRM4CHRM3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5541194-A | PHARMACEUTICAL COMPOSTION USED TO TREAT DEMENTIA | BEECHAM GROUP P.L.C. (GB) | 1996-07-30 | — | — | US | disclosed |
| US-5324724-A | Azabicyclic compounds; Alzheimer's disease treatment | BEECHAM GROUP P.L.C. (GB) | 1994-06-28 | — | — | US | disclosed |
| EP-0594605-A1 | 1-AZABICYCLIC COMPOUNDS, PROCESSES AND PHARMACEUTICAL COMPOSITONS CONTAINING THEM | Beecham Group p.l.c. (GB) | 1994-05-04 | — | — | EP | disclosed |
| EP-0338723-B1 | NOVEL COMPOUNDS | BEECHAM GROUP PLC (GB) | 1993-08-04 | — | — | EP | disclosed |
| US-5217975-A | AZABICYCLIC COMPOUNDS FOR TREATING DEMENTIA | BEECHAM GROUP P.L.C. (GB) | 1993-06-08 | — | — | US | disclosed |
| US-5166357-A | Nitrogen heterocylic compounds used in treatment of dementia in mammals | BEECHAM GROUP P.L.C. (GB) | 1992-11-24 | — | — | US | disclosed |
| US-5110828-A | Treatment or prophylaxis of dementia | BEECHAM GROUP P.L.C. (GB) | 1992-05-05 | — | — | US | disclosed |
| WO-1991013885-A1 | 1-AZABICYCLIC COMPOUNDS, PROCESSES AND PHARMACEUTICAL COMPOSITONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1991-09-19 | — | — | WO | disclosed |
| EP-0402056-A2 | Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them | Beecham Group p.l.c. (GB) | 1990-12-12 | — | — | EP | disclosed |
| EP-0366304-A2 | Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1990-05-02 | — | — | EP | disclosed |
| EP-0338723-A1 | Novel compounds | BEECHAM GROUP PLC (GB) | 1989-10-25 | — | — | EP | disclosed |
| EP-0322182-A2 | Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1989-06-28 | — | — | EP | disclosed |